Skip to main content
. 2021 May 3;11:581172. doi: 10.3389/fonc.2021.581172

Figure 2.

Figure 2

Association Between Expression of SMAD4 and Survival Rates in Patients With Renal Cell Carcinoma (RCC). Disease-specific survival (DSS) with nuclear SMAD4 expression grouped into high versus low expression levels in (A) RCC and (B) ccRCC patients. Number of events and at risk patients on the Kaplan Meier estimates are presented underneath the graphs (A, B).